Yuyu Pharma, Inc. (KRX:000220)

South Korea · Delayed Price · Currency is KRW

3,885.00

+45.00 (1.17%)

Last updated: Sep 1, 2026, 1:19 PM KST

Yuyu Pharma Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	144,371	140,885	133,147	137,210	138,881	115,655
Revenue Growth	6.69%	5.81%	-2.96%	-1.20%	20.08%	17.87%
Gross Profit	55,686	53,586	51,369	48,527	52,966	45,088
Operating Income	13,162	11,019	12,582	-748.94	-592.11	1,200
Net Income	12,180	7,830	8,720	-6,303	-6,273	-2,499
Earnings Per Share	695.09	481.00	513.00	-387.43	-378.31	-157.00
EPS Growth	148.35%	-6.24%	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	27,865	32,705	42,650	32,354	30,778	50,263
Total Debt	28,056	27,923	33,644	39,407	39,276	39,166
Net Cash (Debt)	-191.17	4,783	9,005	-7,053	-8,499	11,097
Net Cash Growth	-	-46.89%	-	-	-	1907.08%
Net Cash Per Share	-9.48	237.87	529.76	-433.55	-512.57	695.34

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	21,049	15,877	24,950	420.86	-6,229	4,509
Capital Expenditures	-15,024	-8,253	-7,112	-4,514	-5,283	-6,073
Free Cash Flow	6,026	7,625	17,838	-4,094	-11,512	-1,565
Free Cash Flow Growth	-46.39%	-57.26%	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	38.57%	38.04%	38.58%	35.37%	38.14%	38.98%
Operating Margin	9.12%	7.82%	9.45%	-0.55%	-0.43%	1.04%
Pretax Margin	9.09%	6.73%	7.50%	-3.97%	-2.74%	-0.33%
Profit Margin	8.44%	5.56%	6.55%	-4.59%	-4.52%	-2.16%
FCF Margin	4.17%	5.41%	13.40%	-2.98%	-8.29%	-1.35%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	5.52	9.08	8.36	-	-	-
Forward PE	-	21.92	21.92	21.92	21.92	21.92
P/FCF Ratio	10.04	9.32	4.09	-	-	-
PS Ratio	0.42	0.51	0.55	0.62	0.74	1.13